Viewing Study NCT01852266


Ignite Creation Date: 2025-12-24 @ 4:30 PM
Ignite Modification Date: 2026-05-22 @ 12:02 PM
Study NCT ID: NCT01852266
Status: COMPLETED
Last Update Posted: 2016-09-15
First Post: 2013-05-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: CIR 285
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators